Controversy is brewing, again, about generic substitution of antiepileptic drugs for seizures

July 2007

Controversy is brewing, again, about generic substitution of antiepileptic drugs for seizures.

The FDA and most state Boards of Pharmacy say it's okay to switch A-rated meds...even those with a narrow therapeutic index.

But there is a move to limit substitution of antiepileptics.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote